A detailed history of Verition Fund Management LLC transactions in Rx Sight, Inc. stock. As of the latest transaction made, Verition Fund Management LLC holds 19,673 shares of RXST stock, worth $881,940. This represents 0.01% of its overall portfolio holdings.

Number of Shares
19,673
Previous 21,351 7.86%
Holding current value
$881,940
Previous $1.28 Million 24.3%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$40.78 - $57.04 $68,428 - $95,713
-1,678 Reduced 7.86%
19,673 $972,000
Q2 2024

Aug 14, 2024

SELL
$50.42 - $64.29 $385,965 - $492,139
-7,655 Reduced 26.39%
21,351 $1.28 Million
Q1 2024

May 14, 2024

BUY
$35.51 - $57.92 $817,049 - $1.33 Million
23,009 Added 383.68%
29,006 $1.5 Million
Q4 2023

Feb 14, 2024

BUY
$20.91 - $40.9 $125,397 - $245,277
5,997 New
5,997 $241,000
Q2 2023

Aug 14, 2023

BUY
$16.37 - $28.9 $154,385 - $272,555
9,431 New
9,431 $271,000

Others Institutions Holding RXST

About RxSight, Inc.


  • Ticker RXST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 27,638,900
  • Market Cap $1.24B
  • Description
  • RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...
More about RXST
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.